Psychopharmacology for Primary Care Physicians

Overview

Primary Care CME: Integrating Medical and Psychiatric Care

Increasingly, primary care practitioners are tasked with diagnosing and treating not only common but also complex and chronic psychiatric disorders. This online CME program will equip you with the knowledge to confidently diagnose and manage prevalent mental health conditions and associated comorbidities like cardiovascular disease, arthritis, and diabetes.

Focused on evidence-based pharmacological interventions and the most recent advancements in the field, Psychopharmacology for Primary Care Physicians will prepare you to handle behavioral and emotional health problems in your day-to-day practice. Delve into a range of continuing medical education topics, including:

• Treatment of depression and bipolar disorder
• Suicide in primary care settings
• Generalized anxiety disorder
• OCD and panic disorder
• Sleep disorder
• Alcohol and substance use disorder
• ADHD
• Mood disorders in pregnancy and postpartum
• Digital technologies
• Child, adolescent, and geriatric psychopharmacology
• When, why, and how to consult psychiatry

Topics / Speakers

Historical Perspectives of Psychopharmacology for General Practitioners – The Case of Manic-Depressive Insanity aka Bipolar Disorders - Luca Pani, MD

Interface of Psychiatry and Medicine – Focus on Cancer and Heart Disease - Charles Nemeroff, MD, PhD

Diagnosis and Treatment of Depression - Nassir Ghaemi, MD, MPH

Bipolar Disorders – Diagnosis and Treatment - Ross Baldessarini, MD, DSc, (hon)

Questions and Answers, Challenging Cases and Discussions with Faculty and Audience - Ross Baldessarini, MD, DSc, (hon), Nassir Ghaemi, MD, MPH, Luca Pani, MD, Charles Nemeroff, MD, PhD, and Paul Summergrad, MD

Recognition and Treatment of Substance Use Disorders in the Primary Care Setting - Roger D. Weiss, MD

Sleep Disorders – Evaluation and Effective Treatment - Sogol Javaheri, MD, MPH

Questions and Answers, Challenging Cases and Discussions with Faculty and Audience - Ross Baldessarini, MD, DSc, (hon), Sogol Javaheri, MD, MPH, David Sheehan, MD, MBA, and Paul Summergrad, MD

Integrating Medical and Psychiatric Care – From Schizophrenia, Bipolar, Depression, Anxiety Disorders, and Beyond - Paul Summergrad, MD

Child and Adolescent Psychopharmacology – How to Treat ADHD, Depression, and Anxiety (and more) - Barbara J. Coffey, MD, MS

Mood Disorders in Pregnancy and Postpartum – What Every Primary Care Provider Needs to Know - Ariadna Forray, MD

Alzheimer’s Disease and Neurocognitive Disorders – Psychopharmacological Treatment of Behavioral Disturbances and Beyond - Elizabeth Crocco, MD

Psychopharmacological Treatment of Anxiety Spectrum Disorders – Generalized Anxiety Disorders (GAD), OCD, and Panic Disorders - Charles Montano, MD

Questions and Answers, Challenging Cases and Discussions with Faculty and Audience - Barbara J. Coffey, MD, MS, Elizabeth Crocco, MD, Nicole Derish, MD, Ariadna Forray, MD, Charles Montano, MD, and Paul Summergrad, MD

Introduction to Digital Psychiatry - Azizi Seixas, PhD

When, Why, How to Consult Psychiatry – Questions and Answers and Discussions with Faculty and Audiences - Barbara J. Coffey, MD, MS, Luca Pani, MD, David Sheehan, MD, MBA, and Azizi Seixas, PhD

Premenstrual Syndrome and Premenstrual Dysphoric Disorder – Diagnosis and Management - Nicole Derish, MD

Faculty

Accreditation

Accreditation

Oakstone Publishing is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation

Oakstone Publishing designates this enduring material for a maximum of 13.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Date of Original Release: May 31, 2024
Termination Date: May 30, 2027
Estimated Time to Complete: 13.00 hours

CME credit is awarded upon successful completion of a course evaluation and post-test.

Learning Objectives

At the completion of this course, you should be able to:

• Develop a comprehensive understanding of psychopharmacology fundamentals and the pharmacokinetics of frequently prescribed psychotropic medications
• Recognize depression in clinical practice
• Understand the role and limitations of standard antidepressant treatments
• Develop strategies to accurately diagnose and manage important mental health symptoms and disorders, including depression, bipolar disorder, anxiety spectrum disorders, (GAD, OCD, Panic), sleep disorders, ADHD, and substance use disorders
• Identify and manage medication side effects, drug interactions, and potential adverse reactions
• Assess the significance of pharmacogenomics in customizing psychopharmacological treatments for individual patients
• Examine the utilization of psychotropic medications in special patient groups, such as children, adolescents, perinatal, pregnant and lactating women, and the elderly, along with patients with comorbid medical conditions
• Explore non-pharmacological treatment alternatives and the significance of a holistic, patient-centered approach to mental health care
• Effectively assess, document, and manage suicidality in primary care settings to protect their patients, and themselves medico-legally
• Assimilate a more balanced perspective on the risks and benefits of benzodiazepine and how to prescribe them correctly and safely
• Understand the concept and significance of digital psychiatry
• Recognize the role of digital tools in psychiatric research and clinical care
• Identify potential challenges and ethical considerations in digital psychiatry
• Recognize when to consult with or refer to psychiatry

Intended Audience

This activity is intended for primary care physicians, pediatricians, psychiatrists, researchers in psychopharmacology and neuroscience, substance abuse and mental health clinicians and researchers, and physician assistants.

Faculty Affiliations Disclosure

Oakstone Publishing has assessed conflict of interest with its faculty, authors, editors, and any individuals who were in a position to control the content of this CME activity. Any identified relevant conflicts of interest were resolved for fair balance and scientific objectivity of studies utilized in this activity. Oakstone Publishing’s planners, content reviewers, and editorial staff disclose no relevant commercial interests.

Disclosure information for individuals in control of the content of the activity can be found at the beginning of each lecture.

Quick Facts

Provider: Oakstone CME

Course Chair:
Barbara J. Coffey, MD, MS
Professor and Chair
Department of Psychiatry and Behavioral Sciences
University of Miami Miller School of Medicine
Program Chair, American Academy of Child and Adolescent Psychiatry
Pediatric Psychopharmacology lead, Canadian International OCD Foundation Accreditation Task Force
Director, Tourette Association of American (TAA) Center of Excellence at UHealth
Former Co-Chair, TAA Medical Advisory Board
TAA Scientific Advisory Board
Associate Editor, Journal of Child and Adolescent Psychopharmacology

Credits: Earn a maximum of 13.00 AMA PRA Category 1 Credits™